Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial
Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13807
Full Text
Open PDFAbstract
Available in full text
Date
July 11, 2019
Authors
Publisher
Wiley